Attached files
| file | filename |
|---|---|
| EX-10.17 - EX-10.17 - ACHILLION PHARMACEUTICALS INC | d115302dex1017.htm |
| EX-31.1 - EX-31.1 - ACHILLION PHARMACEUTICALS INC | d115302dex311.htm |
| EX-10.25 - EX-10.25 - ACHILLION PHARMACEUTICALS INC | d115302dex1025.htm |
| EX-10.16 - EX-10.16 - ACHILLION PHARMACEUTICALS INC | d115302dex1016.htm |
| EX-10.23 - EX-10.23 - ACHILLION PHARMACEUTICALS INC | d115302dex1023.htm |
| EX-10.24 - EX-10.24 - ACHILLION PHARMACEUTICALS INC | d115302dex1024.htm |
| 10-K - FORM 10-K - ACHILLION PHARMACEUTICALS INC | d115302d10k.htm |
| EX-32.1 - EX-32.1 - ACHILLION PHARMACEUTICALS INC | d115302dex321.htm |
| EX-31.2 - EX-31.2 - ACHILLION PHARMACEUTICALS INC | d115302dex312.htm |
| EX-32.2 - EX-32.2 - ACHILLION PHARMACEUTICALS INC | d115302dex322.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (Nos. 333-206276, 333-183152, 333-168902, 333-158241, 333-149729, 333-141661 and 333-138984) and Form S-3 (No. 333-194410) of Achillion Pharmaceuticals, Inc. of our report dated February 25, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
February 25, 2016